New EU pharma strategy looks to future-proof healthcare sector, stimulate innovation and boost access to biosimilars and generics
The new EU Pharmaceutical Strategy, adopted today by the European Commission, is designed to improve and accelerate patients’ access to safe and affordable medicines and address unmet medical needs in the areas of antimicrobial resistance, cancer, and...